Susceptibility of bacterial isolates to gatifloxacin and ciprofloxacin from clinical trials 1997–1998

Comparison of the antibacterial activities of the quinolones Bay 12- 8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin [published erratum appears in J Antimicrob Chemother 1998 Jun;41(6):672]

A. Bauernfeind · Journal of Antimicrobial Chemotherapy · 1997 · 302 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

DNA topoisomerase targets of the fluoroquinolones: A strategy for avoiding bacterial resistance

Xilin Zhao, Chen Xu, John M. Domagala et al. · Proceedings of the National Academy of Sciences · 1997 · 212 citations

Life Sciences, Microbiology, Molecular Biology +17

In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin

J Fung-Tomc, Beatrice Minassian, B Kolek et al. · Journal of Antimicrobial Chemotherapy · 2000 · 122 citations · Full text

Medicine, Microbiology, Pharmacology +12

In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone

M. Hosaka, Tokutaro Yasue, Hideyuki Fukuda et al. · Antimicrobial Agents and Chemotherapy · 1992 · 112 citations · Full text

Life Sciences, Microbiology, Pharmacology +9

Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital

Mario Raviǵlione, J F Boyle, Peter Mariuz et al. · Antimicrobial Agents and Chemotherapy · 1990 · 92 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14